Impact of diabetes on serum biomarkers in heart failure with preserved ejection fraction: insights from the TOPCAT trial.

Of note, DM–treatment interaction terms were not included given the insufficient number of events to detect subtle differences, with any resultant nominally significant P ‐values likely representing false‐positive results.

also in 7,732 other papers